QUICKREADS
India News
‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
Bharat Biotech emphasizes Covaxin's safety record amidst concerns over AstraZeneca's vaccine side effects. Covaxin conducted efficacy trials in India and underwent thorough safety evaluations with no reported incidents. AstraZeneca admits rare side effects in court documents. Serum Institute of India's Covishield, not mRNA-based, uses a viral vector platform for immune response training.

